{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:09Z","timestamp":1788872409537,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81171209"],"award-info":[{"award-number":["81171209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81371406"],"award-info":[{"award-number":["81371406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81000544"],"award-info":[{"award-number":["81000544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2011HZ001"],"award-info":[{"award-number":["ZR2011HZ001"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2010HQ004"],"award-info":[{"award-number":["ZR2010HQ004"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medicine and Health Science Technology Development Project of Shandong Province","award":["2011WSA02018"],"award-info":[{"award-number":["2011WSA02018"]}]},{"name":"Medicine and Health Science Technology Development Project of Shandong Province","award":["2011WSA02020"],"award-info":[{"award-number":["2011WSA02020"]}]},{"name":"Innovation Project for Postgraduates of Jiangsu Province","award":["CXLX13_561"],"award-info":[{"award-number":["CXLX13_561"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.neuropharm.2014.05.032","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T23:16:24Z","timestamp":1401318984000},"page":"121-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Temsirolimus attenuates tauopathy in\u00a0vitro and in\u00a0vivo by targeting tau hyperphosphorylation and autophagic clearance"],"prefix":"10.1016","volume":"85","author":[{"given":"Teng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Chen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Shan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.05.032_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737140.2014.864562","article-title":"Temsirolimus for advanced renal cell carcinoma","volume":"14","author":"Bergmann","year":"2014","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jnc.12203","article-title":"AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans","volume":"125","author":"Georgievska","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbadis.2004.08.007","article-title":"Mutations causing neurodegenerative tauopathies","volume":"1739","author":"Goedert","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1476-5381.2011.01713.x","article-title":"Tau-targeted treatment strategies in Alzheimer's disease","volume":"165","author":"Gotz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pharmthera.2012.07.001","article-title":"Tau as a therapeutic target in neurodegenerative disease","volume":"136","author":"Himmelstein","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1476-5381.2010.01128.x","article-title":"Improving planning, design, reporting and scientific quality of animal experiments by using the Gold Standard Publication Checklist, in addition to the ARRIVE guidelines","volume":"162","author":"Hooijmans","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib11","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/cncr.24239","article-title":"Targeting mTOR in renal cell carcinoma","volume":"115","author":"Hudes","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(98)00867-2","article-title":"Alz-50\/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains","volume":"258","author":"Ikeda","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-7-48","article-title":"Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway","volume":"7","author":"Inoue","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","article-title":"Suppressing inflammation by inhibiting the NF-kappaB pathway contributes to the neuroprotective effect of angiotensin-(1\u20137) in rats with permanent cerebral ischaemia","volume":"167","author":"Jiang","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.neurobiolaging.2013.11.026","article-title":"Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice","volume":"35","author":"Jiang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.phrs.2014.02.008","article-title":"Temsirolimus promotes autophagic clearance of amyloid-beta and provides protective effects in cellular and animal models of Alzheimer's disease","volume":"81","author":"Jiang","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib17","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1073\/pnas.0912793107","article-title":"Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling","volume":"107","author":"Kickstein","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in\u00a0vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib19","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1634\/theoncologist.2009-0178","article-title":"FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma","volume":"15","author":"Kwitkowski","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2013.03.001","article-title":"Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system","volume":"105","author":"Lee","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0306-4522(96)00126-1","article-title":"Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules","volume":"73","author":"Lovestone","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib23","first-page":"309","article-title":"The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes","volume":"78","author":"Lovestone","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2012.11.001","article-title":"mTOR: on target for novel therapeutic strategies in the nervous system","volume":"19","author":"Maiese","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib25","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/awp292","article-title":"Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3","volume":"133","author":"Menzies","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1741-7007-10-78","article-title":"Autophagy impairment: a crossroad between neurodegeneration and tauopathies","volume":"10","author":"Nassif","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuropharm.2012.05.011","article-title":"The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in\u00a0vitro and in\u00a0vivo","volume":"63","author":"Nikkel","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4161\/cbt.23294","article-title":"Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice","volume":"14","author":"Nishikawa","year":"2013","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pneurobio.2013.06.002","article-title":"Impaired autophagy and APP processing in Alzheimer's disease: the potential role of Beclin 1 interactome","volume":"106-107","author":"Salminen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib33","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4161\/auto.21488","article-title":"Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy","volume":"8","author":"Schaeffer","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A\u00a0novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in\u00a0vivo","volume":"35","author":"Sereno","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/cns.12144","article-title":"Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe\/PS1dE9 transgenic mice","volume":"19","author":"Shi","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-2006-9S335","article-title":"GSK-3 is essential in the pathogenesis of Alzheimer's disease","volume":"9","author":"Takashima","year":"2006","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neurobiolaging.2013.11.019","article-title":"Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy","volume":"35","author":"Tan","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3233\/JAD-131148","article-title":"IL12\/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice","volume":"38","author":"Tan","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1460-9568.2003.02820.x","article-title":"Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory","volume":"18","author":"Tischmeyer","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000285516","article-title":"Generation of tau aggregates and clearance by autophagy in an inducible cell model of tauopathy","volume":"7","author":"Wang","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuropharm.2014.05.032_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.05.032_bib43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12035-013-8457-z","article-title":"Autophagy modulation for Alzheimer's disease therapy","volume":"48","author":"Zhu","year":"2013","journal-title":"Mol. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814001993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:58:24Z","timestamp":1589227104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814001993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":43,"alternative-id":["S0028390814001993"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.05.032","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temsirolimus attenuates tauopathy in\u00a0vitro and in\u00a0vivo by targeting tau hyperphosphorylation and autophagic clearance","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}